Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A pilot study. 2009

Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
Unitat de Metabolopaties, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain. acrge@yahoo.es.

A variant phenotype of nonketotic hyperglycinemia has been described by our group associated with pulmonary hypertension. The aim of this study is to investigate the cerebrospinal fluid proteomes to get an insight into this neurodegenerative process producing leukoencephalopathy with white matter spongiform degeneration. DIGE and MALDI-TOF-TOF analyses were performed to carry out the proteomic study of four patients against three normal controls and one additional control of a classical nonketotic hyperglycinemia. The differential proteomic analysis showed a displacement of some series of spots toward the acidic side. The shifted proteins showed a high degree of carbonylation and increased methionine sulfoxidation was found in cystatin C and in vitamin-D-binding protein. These findings in addition to the increase of serum malondialdehyde concentration provide evidence of an oxidative stress in the patients under study, which is probably systemic rather than mainly confined to the CNS. The similarities of our findings with those found in other neurodegenerative diseases suggest that oxidative damage is commonly involved in these pathologies. DIGE technology improves the 2-D PAGE differential analysis and it is suitable in proteomic studies with a small number of cases.

UI MeSH Term Description Entries

Related Publications

Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
July 1999, Journal of child neurology,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
January 2005, Molecular genetics and metabolism,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
July 2022, Journal of inherited metabolic disease,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
November 1978, Neuropadiatrie,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
February 1996, The Journal of pediatrics,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
February 1989, Neurology,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
January 2019, OncoTargets and therapy,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
November 2006, Pediatric neurology,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
January 1978, Monographs in human genetics,
Carlos E Rodríguez, and José A Arranz, and Nuria Colomé, and Joan J Bech-Serra, and Francesc Canals, and Mireia Del Toro, and Encarnació Riudor
May 2021, Proteomics. Clinical applications,
Copied contents to your clipboard!